Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +92.5% | -98.0% | 1 / 3 | +225.5% | +90.96 pp | +372.62 pp | -6.7% | 0.38 | — | 20,6 | +225,5% | −1,5 | +93,8% | — | -4.06 | — |
| Pts | 12 | 0 | 4 | 12 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.790 (close price on 2024-07-25)EPS (TTM): −363,7
Financial charts
1.Revenue & growth
VND bn20,6Q2/26
1.Revenue & growth
VND bn20,6Q2/26
2.Profit & growth
VND bn-1,77Q2/26
3.Profit mix (Penman)
VND bn-27,5Q2/26
4.Margins & cost structure
%1.8%Q2/26
5.Returns & cash cycle
% · days-1.0%Q2/26
6.Earnings quality & cash
VND bn4,06Q2/26
7.Asset structure
VND bn873Q2/26
8.Funding & debt health
VND bn · times873Q2/26
9.Revenue backlog
VND bn70,3Q2/26
10.Valuation
times · %-4,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-22Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-326%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26